Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chad Oh currently holds 2,183,436 shares of AEON Biopharma, Inc. (AEON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chad Oh has been a net neutral trader of AEON stock. They have purchased $0 and sold $0 worth of shares.
Chad Oh's most recent insider trade was on Mar 4, 2026, when they sold 1,316,872 shares at $0.00 per share.
Chad Oh serves as Executive at AEON Biopharma, Inc. (AEON). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Chad Oh holds the position of Executive at AEON Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Chad Oh has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Chad Oh was on Mar 4, 2026, when they purchased $0 worth of AEON shares. This transaction involved 1,316,872 shares at N/A per share.
Chad Oh currently owns 2,183,436 shares of AEON Biopharma, Inc. (AEON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chad Oh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chad Oh has 5 Form 4 filings on record as an insider at AEON Biopharma, Inc..
Set alerts for Chad Oh and 40,000+ other insiders.